FACULTY SCHOLARSHIP
Publications
J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker published, “Drug evaluation – tirbanibulin 1% ointment (Klisyri),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in April 2021. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Jing Wang (PharmD class of 2021), Drug Information Center Resident Brittany Craft and Danial Baker published, “Drug evaluation – relugolix (Orgovyx),” in the FMS in April 2021.
Brittany Craft and Danial Baker published, “Drug evaluation – margetuximab-cmkb (Margenza),” in the FMS in April 2021.
Pharmacotherapy Clinical Professor and Director of Quality Assurance Improvement & Accreditation Preparation Terri Levien, Audrian Santos (PharmD class of 2021), and Danial Baker published, “Drug evaluation – cabotegravir (Vocabira) & cabotegravir and rilpivirine (Cabenuva),” in the FMS in April 2021.
Lee Roy Esposo (PharmD class of 2021), Brittany Craft and Danial Baker published, “Drug evaluation – vibegron (Gemtesa),” in the FMS in April 2021.
Danial Baker published, “Drug utilization evaluation – vibegron (Gemtesa),” in the FMS in April 2021.
Danial Baker published, “Drug evaluation – bimekizumab: preliminary evaluation,” in the FMS in May 2021.
Brittany Craft and Danial Baker published, “Drug evaluation – tepotinib (Tepmetko),” in the FMS in May 2021.
Danial Baker published, “Drug evaluation – evinacumab-dgnb (Evkeeza): Updated Evaluation,” in the FMS in May 2021.
Brittany Craft and Danial Baker published, “Drug evaluation – casimersen (Amondys 45),” in the FMS in May 2021.
VNA Resident Brandon Tabor, Brittany Craft and Danial Baker published, “Drug evaluation – umbralisib (Ukoniq),” in the FMS in May 2021.
Danial Baker published, “Drug utilization evaluation – evinacumab-dgnb (Evkeeza),” in the FMS in May 2021.
Brittany Craft, David Tam (PharmD class of 2021), and Danial Baker published, “Drug evaluation – voclosporin (Lupkynis),” in the FMS in June 2021.
Danial Baker published, “Drug evaluation – sulopenem etzadroxil / probenecid: preliminary evaluation,” in the FMS in July 2021.
Danial Baker published, “Drug evaluation – dasiglucagon (Zegalogue),” in the FMS in June 2021.
Brittany Craft and Danial Baker published, “Drug evaluation – trilaciclib (Cosela),” in the FMS in June 2021.
Terri Levien and Danial Baker published, “Drug evaluation – inolimomab (Leukotac),” in the FMS in June 2021.
Danial Baker published, “Drug utilization evaluation – voclosporin (Lupkynis),” in the FMS in June 2021.
Pharmacotherapy Assistant Professor Cheyenne Newsome and one co-author published, “Strategies to bring transgender and non-binary health care into pharmacy education,” in the American Journal of Pharmaceutical Education in May 2021.
Pharmaceutical Sciences Postdoctoral Research Associate Jinglong Zhang, Pharmaceutical Sciences Postdoctoral Research Associate Fan Zhang, Pharmaceutical Sciences Associate Professor Gang Chen, Boeing Distinguished Professor of Pharmaceutical Sciences Philip Lazarus, Pharmaceutical Sciences Associate Professor Shuwen Wang, and Pharmaceutical Sciences Professor Jiyue Zhu and eight co-authors published, “Polymorphic tandem DNA repeats activate the human telomerase reverse transcriptase gene,” in the peer-reviewed scientific journal Proceedings of the National Academy of Sciences of the United States of America on June 29, 2021.
Jiyue Zhu and two co-authors published “The regulatory function of tandem repeat VNTR2-1 in hTERT gene involves helix-loop-helix family transcription factors,” in the peer-reviewed journal Environmental Molecular Mutagenesis on June 11, 2021.
Pharmaceutical Sciences Assistant Professor Senthil Natesan and two co-authors published “Membrane-facilitated receptor access and binding mechanisms of long-acting β2-adrenergic receptor (β2-AR) agonists,” in Molecular Pharmacology, a peer-reviewed scientific journal from the American Society for Pharmacology and Experimental Therapeutics in August 2021.
Presentations
Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller presented, “Meeting people with diabetes where they are: lessons learned from the home environment,” at the 2021 Oregon & Washington Association of Diabetes Care & Education Specialists (ADCES) Annual Education Conference on April 29, 2021.
Josh Neumiller co-presented the webinar, “Beyond basal: why, when and how to intensify therapy in Type 2 diabetes,” for the American Diabetes Association (ADA) Professional Webinar Series on May 11, 2021.
Josh Neumiller presented, “Diabetes update: medication management and adherence,” for the Diabetes Alliance of Idaho (DAI) on May 19, 2021.
Josh Neumiller presented, “Diabetes: new treatment recommendations and approaches for 2021,” at the 2021 Northwest Pharmacy Convention on June 10, 2021.
Josh Neumiller presented, “Improving outcomes by utilizing antihyperglycemic agents effectively,” for the American Diabetes Association (ADA) Diabetes is Primary Certificate Program.
Josh Neumiller with two co-presenters delivered the American Pharmacists Association (APhA) webinar, “Optimizing CGM and clinical outcomes: the role of the pharmacist,” on June 15, 2021.
Josh Neumiller presented the webinar, “Update on the management of diabetic kidney disease (DKD),” for Postgraduate Healthcare Education on June 30, 2021.
Pharmacotherapy Assistant Professor Cheyenne Newsome presented the webinar, “Pharmacists taking pride in providing care to patients who are LGBTQ+,” for the Washington State Pharmacy Association (WSPA) on June 30, 2021.
United States Transuranium and Uranium Registries (USTUR) Postdoctoral Research Associate Martin Šefl presented, “USTUR whole-body case 0680: 53-year follow-up of a Manhattan project worker,” at the 66th Annual Meeting of the Health Physics Society (HPS Annual Meeting) in Phoenix, Arizona on July 28, 2021. Faculty co-authors included USTUR Assistant Professor Maia Avtandilashvili and USTUR Director and Professor Sergei Tolmachev.
USTUR Assistant Professor George Tabatadze presented, “Comparison of two methods to estimate skeletal plutonium concentration from limited sets of bones,” at the HPS Annual Meeting in Phoenix, Arizona on July 28, 2021. Faculty co-authors included Maia Avtandilashvili and Sergei Tolmachev.
Maia Avtandilashvili and Sergei Tolmachev and one other co-author created the presentation, “Latent bone modeling approach to estimate plutonium activity concentration in human skeleton,” which was presented virtually to the HPS Annual Meeting on July 28, 2021.
Sergei Tolmachev virtually presented, “Effect of osteoporosis on latent bone models to estimate plutonium activity concentration in human skeleton,” to the HPS Annual Meeting on July 28, 2021. Co-authors included Maia Avtandilashvili and one other.
Maia Avtandilashvili and Sergei Tolmachev and one other co-author created the presentation, “Uncertainty evaluation of skeleton plutonium activity concentration estimated from a latent bone model,” which was presented virtually to the HPS Annual Meeting on July 28, 2021.
Sergei Tolmachev virtually presented, “Latent bone modeling approach to select best combination of bones for estimating plutonium activity concentration in human skeleton,” to the HPS Annual Meeting on July 28, 2021. Co-authors included Maia Avtandilashvili and one other.
Maia Avtandilashvili and Sergei Tolmachev and three other co-authors created the presentation, “Analysis of long-term retention of plutonium in the respiratory tract tissues of four workers: bound fraction vs. scar-tissue compartments,” which was presented virtually to the HPS Annual Meeting on July 28, 2021.
Grants & Awards
Pharmaceutical Sciences Assistant Professor Boyang (Jason) Wu has been awarded a five-year, $1.9 million R01 grant by the National Institutes of Health’s National Cancer Institute.
Pharmaceutical Sciences Assistant Professor Anil Singh has been awarded $100,000 over one year from the Arthritis National Research Foundation for the project titled, “Molecular reprogramming of Rheumatoid arthritis synovial fibroblasts by interleukin 6.”
Pharmacotherapy Associate Professor and Director for the Center for Pharmacy Practice Research Kimberly McKeirnan has been awarded $81,910 over six months from Merck for the project titled, “A nation-wide survey to systematically explore the impact of immunizing pharmacy technicians on community pharmacy immunization program resilience.”
Pharmaceutical Sciences Postdoctoral Research Associate Jing Wei has been awarded $446,467 over two years from the Department of Defense for the project titled, “Targeting TPH1 in neuroendocrine prostate cancer.”
Pharmaceutical Sciences Associate Professor and Director of Industry Engagement Bhagwat Prasad has been awarded $121,000 over two years from Novartis for the project titled, “Proteomics characterization of recombinant UDP-glucuronosyltransferases (UGTs) for in vitro to in vivo extrapolation of drug metabolic clearance in human.”
Philip Lazarus has been awarded $50,000 over fifteen months from the Washington Research Foundation for the project titled, “Precision tools for drug metabolizing enzyme research and drug development.”
Senthil Natesan received $50,000 from the Washington Research Foundation for investigating allosteric modulators of opioid and cannabinoid CB1 receptors as potential therapeutics for treating pain and inflammation.
Service
Julie Akers has accepted the position of Associate Dean for External Relations at the WSU College of Pharmacy and Pharmaceutical Sciences, effective July 1, 2021.
Salah-uddin Ahmed has accepted the position of Executive Director of Graduate Programs at the WSU College of Pharmacy and Pharmaceutical Sciences, effective July 1, 2021.
Associate Dean for Faculty and Student Development and Pharmaceutical Sciences Professor and Interim Chair Kathryn Meier was selected as a member of the Washington State Academy of Sciences.
Andrea Lazarus will be continuing in her role as Associate Dean for Research in the college.
Josh Neumiller is serving as a member of the ADCES 2022 Annual Conference Planning Committee.
Josh Neumiller now serves on the editorial board for the journal Kidney and Dialysis.
Josh Neumiller served as chair for the oral abstract session titled, “Novel therapeutic agents and approaches,” at the 81st Scientific Sessions of the ADA on June 28, 2021.
Pharmaceutical Sciences Associate Professor Sue Marsh has been appointed as a Fellow of the American Physiological Society (FAPS).
STUDENT ACHIEVEMENT
Pharmaceutical Sciences and Molecular Medicine students
Dr. Tarana Arman (Clarke lab) passed her final defense on July 13, 2021.
Christopher T. Szlenk (pharmaceutical sciences, Natesan lab), with faculty co-authors Jeevan GC and Senthil Natesan, published “Membrane-facilitated receptor access and binding mechanisms of long-acting β2-adrenergic receptor (β2-AR) agonists,” in Molecular Pharmacology, a peer-reviewed scientific journal from the American Society for Pharmacology and Experimental Therapeutics in August 2021.